Results 91 to 100 of about 7,605 (170)

Occurrence of Pancytopenia Among Patients With Cancer Treated With Poly(Adenosine Diphosphate-Ribose) Polymerase Inhibitors: A Pharmacoepidemiologic Study.

JAMA Oncol, 2021
Morice PM, Chrétien B, Da Silva A, Dolladille C, Alexandre J.   +4 more
europepmc   +1 more source

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models. [PDF]

Cancer, 2020
Santiago-O'Farrill JM, Weroha SJ, Hou X, Oberg AL, Heinzen EP, Maurer MJ, Pang L, Rask P, Amaravadi RK, Becker SE, Romero I, Rubio MJ, Matias-Guiu X, Santacana M, Llombart-Cussac A, Poveda A, Lu Z, Bast RC.   +17 more
europepmc   +1 more source

Role of Poly Adenosine Diphosphate Ribose Polymerase Inhibitors in Advanced Stage Ovarian Cancer. [PDF]

Cureus, 2018
Arora E, Masab M, Jindal V, Riaz I, Gupta S, Varadi G.   +5 more
europepmc   +1 more source

Poly(Adenosine Diphosphate Ribose) Polymerase (PARP) Inhibitors in the Treatment of Advanced Ovarian Cancer: A Narrative Review. [PDF]

Cureus
Dewani D, Jaiswal A, Karwade P.
europepmc   +1 more source

Kinetic Analysis and Metabolism of Poly(Adenosine Diphosphate-Ribose) Polymerase-1-Targeted ¹⁸F-Fluorthanatrace PET in Breast Cancer. [PDF]

J Nucl Med
Young AJ, Pantel AR, Kiani M, Doot RK, Bagheri S, Pryma DA, Farwell MD, Li S, Lee H, Schubert EK, Secreto A, Zuckerman SP, Nayak A, Choi H, Carlin S, DeMichele A, Mankoff DA, Zhou R, Mach RH, McDonald ES.   +19 more
europepmc   +1 more source

Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinic. [PDF]

Cancer
Nassif Haddad E, Javle MM, Yap TA.
europepmc   +1 more source

Positron Emission Tomography Imaging of Poly-(Adenosine Diphosphate-Ribose) Polymerase 1 Expression in Breast Cancer: A Nonrandomized Clinical Trial.

JAMA Oncol, 2020
McDonald ES, Doot RK, Pantel AR, Farwell MD, Mach RH, Maxwell KN, Mankoff DA.   +6 more
europepmc   +1 more source

Poly(adenosine diphosphate-ribose) polymerase as therapeutic target: lessons learned from its inhibitors. [PDF]

Oncotarget, 2017
Cseh AM, Fábián Z, Sümegi B, Scorrano L.   +3 more
europepmc   +1 more source

The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats. [PDF]

Transplantation, 2014
Hatachi G, Tsuchiya T, Miyazaki T, Matsumoto K, Yamasaki N, Okita N, Nanashima A, Higami Y, Nagayasu T.   +8 more
europepmc   +1 more source

Studies on poly adenosine diphosphate-ribose. 8. A method for purification of poly adenosine diphosphate-ribose.

The Journal of biological chemistry, 1970
T, Shima, S, Fujimura, S, Hasegawa, Y, Shimizu, T, Sugimura   +4 more
openaire   +1 more source